Innovation Pharmaceuticals (QB) Stock Price

0.0007 (1.7%)
Volume 597,434
Bid Price 0.015
Ask Price 0.08
News -
Day High 0.043


52 Week Range


Day Low 0.0401
Company Name Stock Ticker Symbol Market Type
Innovation Pharmaceuticals Inc (QB) IPIX OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
0.0007 1.7% 0.0418 16:59:00
Open Price Low Price High Price Close Price Prev Close
0.0401 0.0401 0.043 0.0411
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
39 597,434 $ 0.041309 $ 24,679 - 0.0192 - 0.54
Last Trade Time Type Quantity Stock Price Currency
15:59:55 1,000 $ 0.0418 USD


Draw Mode:

Innovation Pharmaceuticals Inc (QB) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 20.41M 488.23M 342.36M $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
486.61k $ - - - -

more financials information »

Innovation Pharmaceuticals (QB) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical IPIX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.04610.06490.03510.04115772,097,317-0.0043-9.33%
1 Month0.0470.06490.03510.04094851,111,519-0.0052-11.06%
3 Months0.0280.06490.01920.0372826863,6680.013849.29%
6 Months0.04410.06490.01920.0362664739,627-0.0023-5.22%
1 Year0.26320.540.01920.11886331,810,742-0.2214-84.12%
3 Years0.14250.650.01920.19628431,823,031-0.1007-70.67%
5 Years0.751.170.01920.20995321,244,453-0.7082-94.43%

Innovation Pharmaceuticals (QB) Description

An early stage developmental biopharmaceutical company...with six pharmaceutical compound candidates that are designed for treatment of diseases which may be either existing or diseases identified in the future. The Company will initially spend most of its efforts and resources on its anti-cancer compound, Kevetrin, for the treatment of head and neck cancers.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now